stockrowInterCure Ltd. (INCR) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- InterCure Ltd. INCR 3.25 −1.52%
- Shuttle Pharmaceuticals Holdings, Inc. SHPH 5.31 +5.36%
InterCure Ltd. and Shuttle Pharmaceuticals Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $39.1M against $24.0M — 1.6× the size. Shuttle Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. InterCure Ltd. has the higher net margin (4.88% vs 0.00%) and the higher return on invested capital (0.00% vs −36.7%). Across the 12 metrics below, InterCure Ltd. leads on 10 and Shuttle Pharmaceuticals Holdings, Inc. on 2.
Valuation
Profitability
| Metric | INCR | SHPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 32.74% | 0.00% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 4.88% | 0.00% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (90.05%) | (0.80%) |
| Return on assets | 0.00% | (72.47%) | (1.67%) |
| Return on invested capital | 0.00% | (36.73%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack